RecruitingNot ApplicableNCT07114770

Explore the Impacts of One Session and Multiple Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder

Sponsor

Chang Gung Memorial Hospital

Enrollment

60 participants

Start Date

Jul 29, 2025

Study Type

INTERVENTIONAL

Conditions

Autism Spectrum Disorder Theta Burst Stimulation

Summary

This study aims to establish a personalized theta burst stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation, rTMS) protocol considering autistic idiosyncrasy (interindividual variability).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Theta Burst Stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation) for people with autism spectrum disorder and theta burst stimulation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETheta Burst Stimulation (TBS, an advanced variant of repetitive transcranial magnetic stimulation)

Participants will receive a single session of either iTBS or cTBS (600 pulses) targeting the right cerebellar Crus I/II. One week after the initial TBS, they will receive another single session of iTBS or cTBS (600 pulses) at the same site.